The latest news and breakthrough developments from the field of cancer research. We bring you the latest updates from organisations looking into diagnosing and treating all types of cancers using the latest scientific advancements and what is being done to improve patient care.
UCL-led trial shows adding niraparib to standard therapy reduces tumour growth risk in men with advanced prostate cancer by up to 37%, with greater effect in specific genetic subgroups.
Childhood cancer cases are increasing across the European Union, with newly released data from the European Cancer Information System (ECIS) showing a clear upward trend in diagnoses.
Each September, Childhood Cancer Awareness Month brings attention to the fight against pediatric cancers. One of the promising projects currently making waves in this field is MONALISA, a Horizon Europe-funded initiative under the EU Cancer Mission.
Dr Rubina Ahmed, Director of Research, Policy and Services at Blood Cancer UK, explains the urgent need for investment, research, and early diagnosis to beat blood cancer within a generation.
If technology seeks to transform oncology practice, it must solve three big needs: data, training and trust. Annemiek Snoeckx, Co-Chair of the Digital Health Network at the European Cancer Organisation, explains.
Surabhi Srivastava, Commercial Head UK and EU at Qure.ai, discusses how integrating artificial intelligence can reduce chest X-ray reporting times and accelerate early lung cancer diagnosis.
Researchers at the University of Warwick have created a quantum diamond sensor, a diamond-based magnetometer capable of accurately detecting cancer cells.
Researchers have shown that AI can detect early laryngeal cancer and related lesions from voice recordings, offering a simple, non-invasive screening option.
University Hospital Southampton is implementing Aiforia’s PD-L1 lung cancer AI solution to assess PD-L1 staining in lung cancer specimens. Dr Vipul Foria and Dr Victoria Elliot describe their journey so far.
Researchers have developed a lung cancer treatment that delivers healthy mitochondria to tumours, boosting T cell activity and improving the effectiveness of cisplatin chemotherapy with reduced toxicity.
The Lancet Commission finds that over three in five liver cancer cases are due to modifiable risks like hepatitis, alcohol, and obesity, highlighting urgent prevention needs.
